Long-term persistence of humoral immunity after SARS-CoV-2 mRNA booster vaccination in SARS-CoV-2-naïve individuals

Vaccine: X · Published 2026-07-28 · DOI 10.1016/j.jvacx.2026.100882

Free full text

Authors (14)

Yoshifumi Uwamino, Kengo Nagashima, Shiho Tanaka, Toshinobu Kurafuji, Yuta Fujimori, Akiko Tanabe, Akemi Ohno, Tomoko Arai, Ayako Shibata, Masatoshi Wakui, Mitsuru Murata, Ho Namkoong, Yasunori Sato, Hiromichi Matsushita

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Uwamino, Y., Nagashima, K., Tanaka, S., et al. (2026). Long-term persistence of humoral immunity after SARS-CoV-2 mRNA booster vaccination in SARS-CoV-2-naïve individuals. Vaccine: X. https://doi.org/10.1016/j.jvacx.2026.100882

Related articles

• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China · The Lancet · 2020 · Cites or is cited by this article
• Descriptive comparison of COVID-19 and influenza in Asia-Pacific in 2024–2025 · Vaccine: X · 2026 · Same journal
• Hepatitis B vaccine-induced immunity among hill tribe and stateless children in northern Thailand · Vaccine: X · 2026 · Same journal
• Immunogenicity and protective efficacy of inactivated and vectored H9N2 vaccines in broilers with maternally derived antibodies · Vaccine: X · 2026 · Same journal
• A novel in silico construction of a DNA vaccine expressing broad-spectrum CD8 T-cell multi-epitope antigen against high-risk human papillomavirus infection · Vaccine: X · 2026 · Same journal
• Association of body mass index with COVID-19 risk and vaccine effectiveness in children · Vaccine: X · 2026 · Same journal
• Measuring vaccination attitudes: validated methods and predictive models with evidence from Covid-19 research · Vaccine: X · 2026 · Same journal
• Addressing the social nature of vaccination hesitancy in humanitarian immunization programs. An experience of developing a qualitative assessment tool on vaccination decision making in Médecins Sans Frontières, MSF · Vaccine: X · 2026 · Same journal
• Long-term evolution of pneumococcal serotypes linked to invasive diseases in Colombia and potential coverage by new pneumococcal vaccines: An analysis of national surveillance data between 2005-2023 · Vaccine: X · 2026 · Same journal
• Human papillomavirus (HPV) prevalence and genoprevalence in Jimma town of Southwest Ethiopia: a population-based study · Vaccine: X · 2026 · Same journal